Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-04

FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for insulin lispro from Eli Lilly, updating the product under an existing biologics license.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • insulin lispro (insulin lispro)

Snippet

SUPPL AP for INSULIN LISPRO (INSULIN LISPRO)